| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/04/2011 | CN102038938A Therapies for chronic inflammatory demyelinating polyneuropathy using interferon-beta |
| 05/04/2011 | CN101244268B Eimeria Tenella complex immunity regulation type DNA vaccine |
| 05/04/2011 | CN101224302B Real time individuation poultry egg antibody preparation for anti Hepatitis B or C virus and preparing method and application thereof |
| 05/04/2011 | CN101215544B Inflammation-inhibiting compounds |
| 05/04/2011 | CN101148475B Human breast cancer resisting recombination immunotoxin M4G3/ScFv-PE40 |
| 05/04/2011 | CN101039962B Measuring degree of polymerisation for capsular saccharides that contain sialic acid |
| 05/04/2011 | CN101039692B Consortium of nitrifying bacteria |
| 05/03/2011 | USRE42324 Compound for treatment of allergy and asthma |
| 05/03/2011 | US7935807 Chicken RNA polymerase I promoter and the use thereof |
| 05/03/2011 | US7935805 Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof |
| 05/03/2011 | US7935804 Engineered Listeria and methods of use thereof |
| 05/03/2011 | US7935794 MAdCAM antibodies |
| 05/03/2011 | US7935793 variable heavy chain amino acid sequence of SEQ ID NO. 50 and a variable light chain amino acid sequence of SEQ ID NO. 48, designated herein as HuAIP12 |
| 05/03/2011 | US7935784 Immunoglobulin fusion which targets extracellullar domain of human estrogen receptor for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 05/03/2011 | US7935682 Wound healing dressing for enhancing fibrocyte formation |
| 05/03/2011 | US7935675 Immunostimulatory nucleic acid molecules |
| 05/03/2011 | US7935531 Methods for the early diagnosis of ovarian cancer |
| 05/03/2011 | US7935490 Immunodiagnostic assays using reducing agents |
| 05/03/2011 | US7935357 Proteins with repetitive Bacterial-Ig-like (Big) domains present in Leptospira species |
| 05/03/2011 | US7935356 Attenuated Mycoplasma gallisepticum strains |
| 05/03/2011 | US7935355 Antigen to stimulate immunology response; inoculating birds against Salmonella; reduce shedding of Escherichia |
| 05/03/2011 | US7935354 Generation of new BCG vaccine strains protecting against the establishment of latent Mycobacterium tuberculosis infection and reactivation from the latent or persistent state |
| 05/03/2011 | US7935353 Compounds and methods for diagnosis and immunotherapy of tuberculosis |
| 05/03/2011 | US7935352 Compositions and methods for vaccinating against HSV-2 |
| 05/03/2011 | US7935351 Use of CPG oligodeoxynucleotides to induce angiogenesis |
| 05/03/2011 | US7935349 CRMP4b inhibitory peptide |
| 05/03/2011 | US7935348 Combination therapy for the treatment of Alzheimer's disease |
| 05/03/2011 | US7935347 DNA molecule corresponding to a nucleotide sequence of a cereal pollen major allergen; therapy of pollen-allergy diseases |
| 05/03/2011 | US7935346 Medicament for the two-step perioperative therapy of solid tumours |
| 05/03/2011 | US7935345 Monoclonal antibodies that specifically bind to and neutralize bacillus anthracis toxin, compositions, and methods of use |
| 05/03/2011 | US7935344 Human anti-IL-23 antibodies, compositions, methods and uses |
| 05/03/2011 | US7935343 Immunoglobulin specific to interleukin-13 (IL-13) for use in prevention and treatment of asthma, fibrosis, skin and cell proliferative disorders |
| 05/03/2011 | US7935342 Methods for treating obesity by administering a trkB antagonist |
| 05/03/2011 | US7935341 Antibodies to complementary peptides of thrombin or portions thereof |
| 05/03/2011 | US7935340 Antibodies to IL-6 and use thereof |
| 05/03/2011 | US7935339 Inhibition of the CD95 ligand/receptor system for the treatment of neurological disorders and injuries |
| 05/03/2011 | US7935338 Antibodies to treat cancer |
| 05/03/2011 | US7935333 Vaccine against brain protein; antiepileptic agents |
| 05/03/2011 | US7935252 Methods of treating Alzheimer's Disease with an apheresis device |
| 05/03/2011 | CA2499430C Chicken astrovirus type 2 |
| 05/03/2011 | CA2454048C Therapeutic agents comprising pro-apoptotic proteins |
| 05/03/2011 | CA2376600C Porcine circovirus recombinant poxvirus vaccine |
| 05/03/2011 | CA2328485C Humanized antibodies that recognize verotoxin ii and cell line producing same |
| 05/03/2011 | CA2293805C Use of mhc class ii ligands as adjuvant for vaccination and of lag-3 in cancer treatment |
| 05/03/2011 | CA2260761C Vaccine comprising antigens bound to carriers through labile bonds |
| 05/03/2011 | CA2246297C Use of an anti-human tnf-alpha monoclonal antibody in the manufacture of a therapeutic formulation for treating a thrombotic disorder |
| 04/29/2011 | CA2741418A1 Detection and modulation of cytochrome c acetylation |
| 04/28/2011 | WO2011050344A2 Cancer immunotherapy and method of treatment |
| 04/28/2011 | WO2011050319A2 Inhibiting the deleterious effect of anthracyclines |
| 04/28/2011 | WO2011050299A2 Adenovirus infection in animals |
| 04/28/2011 | WO2011050263A2 Systemic immunosuppression in the treatment of age related macular degeneration and diabetic retinopathy |
| 04/28/2011 | WO2011050262A2 Dual variable domain immunoglobulins and uses thereof |
| 04/28/2011 | WO2011050259A1 Compositions, methods for treatment, and diagnoses of autoimmunity-related disorders and methods for making such compositions |
| 04/28/2011 | WO2011050242A1 Anti-gcc antibody molecules and related compositions and methods |
| 04/28/2011 | WO2011050222A2 Therapeutic compositions that disrupt the hydrogen bonded ring structure in gp41 and methods for treating hiv |
| 04/28/2011 | WO2011050194A1 Methods and compositions for modulating hepsin activation of macrophage-stimulating protein |
| 04/28/2011 | WO2011050192A1 Modulation of axon degeneration |
| 04/28/2011 | WO2011050180A1 Novel dosing regimen and method of treatment |
| 04/28/2011 | WO2011050168A2 Rsv immunogens, antibodies and compositions thereof |
| 04/28/2011 | WO2011050152A2 Site-specific modification of proteins |
| 04/28/2011 | WO2011050107A2 Compositions and methods for delivery of therapeutic agents to the cns |
| 04/28/2011 | WO2011050106A2 Anti-cd3 antibody dosing in autoimmune disease |
| 04/28/2011 | WO2011050104A2 Methods of using anti-cd3 antibodies to prevent weight gain |
| 04/28/2011 | WO2011049868A1 Modulators of hepatocyte growth factor activator |
| 04/28/2011 | WO2011049835A1 Human parvovirus: humink parvovirus |
| 04/28/2011 | WO2011049810A2 Compositions and methods for treating inflammation and fibrosis |
| 04/28/2011 | WO2011049758A1 Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors |
| 04/28/2011 | WO2011049590A1 Producing an immune response for reducing the risk of developing brucellosis |
| 04/28/2011 | WO2011049412A2 Human recombinant monoclonal antibody that specifically binds to vcam-1 and inhibits adhesion and transmigration between leukocytes and endothelial cells |
| 04/28/2011 | WO2011049346A2 Compositions for improving migration potential of stem cells |
| 04/28/2011 | WO2011049082A1 INTEGRIN α8Β1-SPECIFIC MONOCLONAL ANTIBODY |
| 04/28/2011 | WO2011048766A1 Carbonic anhydrase i serving as novel antigen to be used for treatment of autoimmune diseases |
| 04/28/2011 | WO2011048386A1 Influenza vaccine |
| 04/28/2011 | WO2011048248A1 Adjuvant for vaccines, vaccines that comprise said adjuvant and uses thereof |
| 04/28/2011 | WO2011048215A1 Detection of a circovirus in calves suffering from bovine neonatal pancytopenia |
| 04/28/2011 | WO2011048041A1 Streptococcal combi-vaccine |
| 04/28/2011 | WO2011047531A1 Novel immunological adjuvant and vaccines comprising said adjuvant |
| 04/28/2011 | WO2011047442A1 Modified variable domain molecules and methods for producing and using same |
| 04/28/2011 | WO2011032003A9 Immunization to reduce neurotoxicity during treatment with cytolytic viruses |
| 04/28/2011 | WO2011027956A3 Extracellular vesicles derived from gram-positive bacteria, and disease model using same |
| 04/28/2011 | WO2011026966A3 Method of treating eosinophilic esophagitis |
| 04/28/2011 | WO2011013034A4 Antigenic tau peptides and uses thereof |
| 04/28/2011 | WO2011012662A9 Mycobacterium mutants for vaccines with improved protective efficacy |
| 04/28/2011 | WO2011008974A3 Rsv f protein compositions and methods for making same |
| 04/28/2011 | WO2011005377A3 Compositions and methods comprising vegfr-2 and vegfr-3 antagonists for the treatment of metastatic disease |
| 04/28/2011 | WO2010138955A3 Methods and compositions for treating neoplasia |
| 04/28/2011 | WO2010138885A3 Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses |
| 04/28/2011 | WO2010129895A3 Cd133 epitopes |
| 04/28/2011 | WO2010119245A3 Gamma - glutamyl transpeptidase attenuated francisella |
| 04/28/2011 | WO2010022225A9 Dock-and-lock (dnl) vaccines for cancer therapy |
| 04/28/2011 | US20110099647 Antibodies against cd38 for treatment of multiple myeloma |
| 04/28/2011 | US20110097794 Whitefly Ecdysone Receptor Nucleic Acids, Polypeptides, and Uses Thereof |
| 04/28/2011 | US20110097418 Compositions and methods for treating influenza |
| 04/28/2011 | US20110097417 Melan-a-carrier conjugates |
| 04/28/2011 | US20110097392 Antibody bound synthetic vesicle containing molecules for deliver to central and peripheral nervous system cells |
| 04/28/2011 | US20110097381 Conformable tissue repair implant capable of injection delivery |
| 04/28/2011 | US20110097367 Monolithic in-situ cross-linked alginate implants |
| 04/28/2011 | US20110097362 Transmucosal Administration of Aggregated Antigens |
| 04/28/2011 | US20110097361 Method of inducing tolerance to an allergen |
| 04/28/2011 | US20110097360 Streptococcus pneumoniae pilus antigens |